(Q34207151)

31 July 2017

Association between pathological and MRI findings in multiple sclerosis. (English)

1 reference

magnetic resonance imaging

31 July 2017

0 references

0 references

3

Frederik Barkhof

1 reference

31 July 2017

6

Giancarlo Comi

1 reference

31 July 2017

11

Franz Fazekas

1 reference

31 July 2017

8

Nicola De Stefano

1 reference

31 July 2017

14

David H Miller

1 reference

31 July 2017

1

Massimo Filippi

1 reference

31 July 2017

Nikos Evangelou

10

1 reference

ORCID Public Data File 2021

Maria A Rocca

2

object named as

Maria A Rocca

1 reference

31 July 2017

12

Jeroen J G Geurts

1 reference

31 July 2017

17

Hans Lassmann

1 reference

31 July 2017

4

Wolfgang Brück

1 reference

31 July 2017

7

Gabriele DeLuca

1 reference

31 July 2017

Jacqueline T Chen

5

1 reference

31 July 2017

Bradley J Erickson

9

1 reference

31 July 2017

Claudia Lucchinetti

13

1 reference

31 July 2017

Daniel Pelletier

15

1 reference

31 July 2017

Bogdan F Gh Popescu

16

1 reference

31 July 2017

Attendees of the Correlation between Pathological MRI findings in MS workshop

18

1 reference

31 July 2017

19 March 2012

1 reference

31 July 2017

1 reference

31 July 2017

11

1 reference

31 July 2017

4

1 reference

31 July 2017

349-360

1 reference

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

MR imaging of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

MRI assessment of iron deposition in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Axonal loss in normal-appearing white matter in a patient with acute MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Diffusion tensor imaging of post mortem multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Corpus callosum damage and cognitive dysfunction in benign MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

The blood-brain barrier in cortical multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A case of multiple sclerosis presenting with inflammatory cortical demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Inflammatory cortical demyelination in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Grey Matter Pathology in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Cortical lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Accumulation of cortical lesions in MS: relation with cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Gray matter pathology in (chronic) MS: modern views on an early observation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Thalamic neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Regional grey matter atrophy in clinically isolated syndromes at presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A comparison of the pathology of primary and secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Demyelination versus remyelination in progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

The contribution of demyelination to axonal loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Spinal cord atrophy and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A multicenter assessment of cervical cord atrophy among MS clinical phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Optic nerve imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Serial magnetization transfer imaging in acute optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Disruption of central nervous system barriers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Deep Gray Matter Perfusion in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970003-0

7 January 2021

10.1016/S1474-4422(12)70003-0

Identifiers

DOI

1 reference

31 July 2017

1 reference